Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | CPA1 | P15085 | 1/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
| ▸ | NAMPT | P43490 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL442805 | 0.84 | HRH4 (0.37) | TGFBR1HRH4HRH3RXFP1MEN1 | |
| SCHEMBL29518826 | 0.83 | TGFBR1 (0.46) | TGFBR1RXFP1MEN1KMT2ATSHR | |
| SCHEMBL23761385 | 0.81 | ACE2 (0.37) | TGFBR1HRH4HRH3MEN1KMT2A | |
| SCHEMBL366427 | 0.80 | CYP2D6 (0.52) | TGFBR1RXFP1MEN1KMT2ATSHR | |
| SCHEMBL10750333 | 0.80 | ANPEP (0.36) | TGFBR1RXFP1MEN1KMT2ATSHR | |
| SCHEMBL491544 | 0.80 | TGFBR1 (0.35) | TGFBR1RXFP1MEN1KMT2ATSHR | |
| SCHEMBL14931 | 0.79 | TGFBR1 (0.37) | TGFBR1RXFP1TSHRUSP2THRB | |
| SCHEMBL566592 | 0.79 | TGFBR1 (0.34) | TGFBR1RXFP1MEN1KMT2A | |
| SCHEMBL3734949 | 0.79 | GAA (0.44) | TGFBR1RXFP1MEN1KMT2A | |
| SCHEMBL16097 | 0.78 | TGFBR1 (0.39) | TGFBR1RXFP1MEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8672466-B2 | Ink composition, ink set and image forming method | FUJIFILM CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| US-8303943-B2 | Ampholytic copolymer based on quaternized nitrogen-containing monomers | BASF SE (DE) | 2012-11-06 | — | — | US | disclosed |
| US-20120069084-A1 | INK COMPOSITION, INK SET AND IMAGE FORMING METHOD | FUJIFILM CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| US-20100068156-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2010-03-18 | — | — | US | disclosed |
| EP-2064253-B1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| WO-2009103735-A1 | COMPOSITION CONTAINING AN AMPHOLYTIC COPOLYMER ON THE BASIS OF QUATERNISED MONOMERS CONTAINING NITROGEN AND AT LEAST ONE POLYMER THAT DIFFERS FROM SAID COPOLYMER, AND USE THEREOF | BASF SE (DE) | 2009-08-27 | — | — | WO | disclosed |
| EP-2064253-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2009-06-03 | — | — | EP | disclosed |
| WO-2008031892-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2008-03-20 | — | — | WO | disclosed |
| EP-0258999-B1 | PROCESS FOR PREPARING ISOTHIAZOLONES | ROHM AND HAAS COMPANY (US) | 1991-05-02 | — | — | EP | disclosed |
| US-4868310-A | Process for preparing isothiazolones | ROHM AND HAAS COMPANY (US) | 1989-09-19 | — | — | US | disclosed |
| EP-0258999-A1 | Process for preparing isothiazolones | ROHM AND HAAS COMPANY (US) | 1988-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100068156-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | NGLY1, NAAA, NIT2 | TGFBR1 3924/4885FAAH 257/4885CNR1 797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.